Ustekinumab Dose Intensification in Patients With Crohn's Disease: Comparing Every 4 and Every 6-Week Dosing

被引：0
|
作者：
Dalal, Rahul S. [1 ]
Njie, Cheikh [1 ]
Sanchit, Gupta [1 ]
Allegretti, Jessica R. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S0807
引用
收藏
页码：S414 / S414
页数：1
相关论文
共 50 条
  • [1] Intravenous Ustekinumab Reinduction Is Effective in Prior Biologic Failure Crohn's Disease Patients Already on Every-4-Week Dosing
    Sedano, Rocio
    Guizzetti, Leonardo
    McDonald, Cassandra
    Jairath, Vipul
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (07) : 1497 - +
  • [2] Effectiveness and Safety of Ustekinumab Intensification at 90 mg Every 4 Weeks in Crohn's Disease: A Multicentre Study
    Fumery, Mathurin
    Peyrin-Biroulet, Laurent
    Nancey, Stephane
    Altwegg, Romain
    Gilletta, Cyrielle
    Veyrard, Pauline
    Bouguen, Guillaume
    Viennot, Stephanie
    Poullenot, Florian
    Filippi, Jerome
    Buisson, Anthony
    Bozon, Anne
    Brazier, Franck
    Pouillon, Lieven
    Flourie, Bernard
    Boivineau, Lucile
    Siproudhis, Laurent
    Laharie, David
    Roblin, Xavier
    Diouf, Momar
    Treton, Xavier
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (02): : 222 - 227
  • [3] USTEKINUMAB DOSE INTENSIFICATION IN PAEDIATRIC CROHN'S DISEASE
    Rodriguez-Mauriz, Rosa
    Segui Solanes, Carlos
    Masiques Mas, Isabel
    Rudi Sola, Nuria
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (07) : 1149 - 1149
  • [4] EFFICACY OF DOSE INTENSIFICATION OF USTEKINUMAB IN CROHN'S DISEASE
    Ramaswamy, Pradeep Kakkadasam
    Moattar, Hadi
    Sawyer, Elise A.
    James, Rayshelle
    Edwards, John
    Shukla, Dheeraj
    GASTROENTEROLOGY, 2020, 158 (06) : S956 - S956
  • [5] Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn's disease
    Fumery, M.
    Peyrin-biroulet, L.
    Nancey, S.
    Altwegg, R.
    Veyrard, P.
    Bouguen, G.
    Viennot, S.
    Poullenot, F.
    Filippi, J.
    Buisson, A.
    Bozon, A.
    Gilletta, C.
    Brazier, F.
    Pouillon, L.
    Flourie, B.
    Boivineau, L.
    Siproudhis, L.
    Laharie, D.
    Roblin, X.
    Treton, X.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S16 - S16
  • [6] Similar clinical outcomes for natalizumab patients switching to every-6-week dosing versus remaining on every-4-week dosing in real-world practice
    Butzkueven, H.
    Kappos, L.
    Spelman, T.
    Trojano, M.
    Wiendl, H.
    Su, R.
    Hyde, R.
    Licata, S.
    Ho, P. -R.
    Campbell, N.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 308 - 308
  • [7] Predictors of Ustekinumab Failure After Dose Intensification Among Patients With Crohn's Disease
    Njie, Cheikh
    Sanchit, Gupta
    Allegretti, Jessica R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S324 - S325
  • [8] Ustekinumab Dose Intensification Can Be Effective in Crohn's Disease Patients Not Responding to Induction
    Young, Ari
    Tsistrakis, Steven
    Rubinov, Jason
    Kohan, Elizabeth
    Hirten, Robert
    Ungaro, Ryan
    Cohen, Benjamin
    Cho, Judy
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Oikonomou, Ioannis
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S350 - S351
  • [9] A Randomized Controlled Study Comparing Once-Weekly to Every-2-Week and Every-4-Week Dosing of Epoetin Alfa in CKD Patients with Anemia
    Pergola, Pablo E.
    Gartenberg, Gary
    Fu, Min
    Sun, Steven
    Wofson, Marsha
    Bowers, Peter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04): : 598 - 606
  • [10] Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification
    Dalal, Rahul S.
    Njie, Cheikh
    Marcus, Jenna
    Gupta, Sanchit
    Allegretti, Jessica R.
    JOURNAL OF ANIMAL SCIENCE, 2022, 100 (09) : 1294 - 1301
12345